Second, we showed that NKILA expression decreased significantly with advanced disease staging in NPC clinical tissue samples, further research showed low expression of NKILA was correlated with metastasis (P< 0.05), larger tumor size (T stage, P <0.05), and late clinical stage (TNM stage, P < 0.01). This evidence concerns the gene NKILA and neoplasm.